These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32582612)

  • 1. A Structural Competency Curriculum for Primary Care Providers to Address the Opioid Use Disorder, HIV, and Hepatitis C Syndemic.
    Bagchi AD
    Front Public Health; 2020; 8():210. PubMed ID: 32582612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strengthening systems of care for people with or at risk for HIV, HCV and opioid use disorder: a call for enhanced data collection.
    Eller AJ; DiDomizio EE; Madden LM; Oliva JD; Altice FL; Johnson KA
    Ann Med; 2022 Dec; 54(1):1714-1724. PubMed ID: 35775786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Syndemic of Opioid Misuse, Overdose, HCV, and HIV: Structural-Level Causes and Interventions.
    Perlman DC; Jordan AE
    Curr HIV/AIDS Rep; 2018 Apr; 15(2):96-112. PubMed ID: 29460225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mHealth application for improving HIV and Hepatitis C knowledge in individuals with opioid use disorder: A pilot study.
    Ochalek TA; Heil SH; Higgins ST; Badger GJ; Sigmon SC
    Drug Alcohol Depend; 2018 Sep; 190():224-228. PubMed ID: 30056321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an Interdisciplinary Telehealth Model of Provider Training and Comprehensive Care for Hepatitis C and Opioid Use Disorder in a High-Burden Region.
    Sherbuk JE; Knick TK; Canan C; Ross P; Helbert B; Cantrell ES; Cantrell CJ; Stallings R; Barron N; Jordan D; McManus KA; Dillingham R
    J Infect Dis; 2020 Sep; 222(Suppl 5):S354-S364. PubMed ID: 32877562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Dynamic Spatial Factor Model to Describe the Opioid Syndemic in Ohio.
    Kline D; Waller LA; McKnight E; Bonny A; Miller WC; Hepler SA
    Epidemiology; 2023 Jul; 34(4):487-494. PubMed ID: 37155617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring conceptual and theoretical frameworks for nurse practitioner education: a scoping review protocol.
    Wilson R; Godfrey CM; Sears K; Medves J; Ross-White A; Lambert N
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):146-55. PubMed ID: 26571290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying Areas with Disproportionate Local Health Department Services Relative to Opioid Overdose, HIV and Hepatitis C Diagnosis Rates: A Study of Rural Illinois.
    McLuckie C; Pho MT; Ellis K; Navon L; Walblay K; Jenkins WD; Rodriguez C; Kolak MA; Chen YT; Schneider JA; Zahnd WE
    Int J Environ Res Public Health; 2019 Mar; 16(6):. PubMed ID: 30893862
    [No Abstract]   [Full Text] [Related]  

  • 9. Training the next generation of providers in addiction medicine.
    Rasyidi E; Wilkins JN; Danovitch I
    Psychiatr Clin North Am; 2012 Jun; 35(2):461-80. PubMed ID: 22640766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multimorbidity model for estimating health outcomes from the syndemic of injection drug use and associated infections in the United States.
    Chiosi JJ; Mueller PP; Chhatwal J; Ciaranello AL
    BMC Health Serv Res; 2023 Jul; 23(1):760. PubMed ID: 37461007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Student and educator experiences of maternal-child simulation-based learning: a systematic review of qualitative evidence protocol.
    MacKinnon K; Marcellus L; Rivers J; Gordon C; Ryan M; Butcher D
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):14-26. PubMed ID: 26447004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model.
    Cloutier RM; Cole ES; McDonough BL; Lomauro DA; Miller JP; Talbert AL; Bear TM; Bridges NC; Foulds AL; Taber R; Gordon AJ; Cochran GT; Kmiec J; Donohue JM; Kelley D; DiDomenico E; Adair D; Pringle JL
    Implement Res Pract; 2023; 4():26334895231152808. PubMed ID: 37091535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral Hepatitis and Human Immunodeficiency Virus Testing and Linkage to Care for Individuals Enrolled in an Opioid Treatment Program.
    Rowan SE; Kamis KF; Beum R; Bryan K; Gawenus L; Colon Sanchez D; Hurley H
    J Infect Dis; 2020 Sep; 222(Suppl 5):S384-S391. PubMed ID: 32877565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study protocol for Project I-Test: a cluster randomized controlled trial of a practice coaching intervention to increase HIV testing in substance use treatment programs.
    Frimpong JA; Parish CL; Feaster DJ; Gooden LK; Nelson MC; Matheson T; Siegel K; Haynes L; Linas BP; Assoumou SA; Tross S; Kyle T; Liguori TK; Toussaint O; Annane D; Metsch LR
    Trials; 2023 Sep; 24(1):609. PubMed ID: 37749635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Medication Treatment of Opioid Use Disorder Among Primary Care Patients with Hepatitis C and HIV.
    Tsui JI; Akosile MA; Lapham GT; Boudreau DM; Johnson EA; Bobb JF; Binswanger IA; Yarborough BJH; Glass JE; Rossom RC; Murphy MT; Cunningham CO; Arnsten JH; Thakral M; Saxon AJ; Merrill JO; Samet JH; Bart GB; Campbell CI; Loree AM; Silva A; Stotts AL; Ahmedani B; Braciszewski JM; Hechter RC; Northrup TF; Horigian VE; Bradley KA
    J Gen Intern Med; 2021 Apr; 36(4):930-937. PubMed ID: 33569735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?
    Rich KM; Bia J; Altice FL; Feinberg J
    Curr HIV/AIDS Rep; 2018 Jun; 15(3):266-275. PubMed ID: 29774442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "No more falling through the cracks": A qualitative study to inform measurement of integration of care of HIV and opioid use disorder.
    Oldfield BJ; Muñoz N; Boshnack N; Leavitt R; McGovern MP; Villanueva M; Tetrault JM; Edelman EJ
    J Subst Abuse Treat; 2019 Feb; 97():28-40. PubMed ID: 30577897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids.
    Barocas JA; Morgan JR; Fiellin DA; Schackman BR; Eftekhari Yazdi G; Stein MD; Freedberg KA; Linas BP
    Int J Drug Policy; 2019 Oct; 72():160-168. PubMed ID: 31085063
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.